{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:34:55Z","timestamp":1787243695224,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["UL1TR002529"],"award-info":[{"award-number":["UL1TR002529"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1038\/s41388-020-01434-5","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T11:04:29Z","timestamp":1598353469000},"page":"6286-6299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-9373","authenticated-orcid":false,"given":"Xiyin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian R. H.","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-703X","authenticated-orcid":false,"given":"Chad J.","family":"Creighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Buechlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco J.","family":"DeMayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Lydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-3971","authenticated-orcid":false,"given":"Shannon M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"1434_CR2","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","volume":"95","author":"WT Creasman","year":"2006","unstructured":"Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the Corpus Uteri. Int J Gynaecol Obstet. 2006;95 Suppl 1:S105\u2013S143.","journal-title":"Int J Gynaecol Obstet"},{"key":"1434_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3802\/jgo.2015.26.1.25","volume":"26","author":"TJ Vogel","year":"2015","unstructured":"Vogel TJ, Knickerbocker A, Shah CA, Schiff MA, Isacson C, Garcia RL, et al. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers. J Gynecol Oncol. 2015;26:25\u201331.","journal-title":"J Gynecol Oncol"},{"key":"1434_CR4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bjc.2015.268","volume":"113","author":"MA Versluis","year":"2015","unstructured":"Versluis MA, de Jong RA, Plat A, Bosse T, Smit VT, Mackay H, et al. Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters. Br J Cancer. 2015;113:786\u201393.","journal-title":"Br J Cancer"},{"key":"1434_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","volume":"40","author":"CP Morrow","year":"1991","unstructured":"Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55\u201365.","journal-title":"Gynecol Oncol"},{"key":"1434_CR6","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404\u201311.","journal-title":"Lancet"},{"key":"1434_CR7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","volume":"174","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, et al. Comprehensive characterization of cancer driver genes and mutations. Cell. 2018;174:1034\u20135.","journal-title":"Cell"},{"key":"1434_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11610-1","volume":"10","author":"J Vedanayagam","year":"2019","unstructured":"Vedanayagam J, Chatila WK, Aksoy BA, Majumdar S, Skanderup AJ, Demir E, et al. Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis. Nat Commun. 2019;10:3682.","journal-title":"Nat Commun"},{"key":"1434_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"1434_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2017.08.027","volume":"147","author":"X Wang","year":"2017","unstructured":"Wang X, Ivan M, Hawkins SM. The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer. Gynecol Oncol. 2017;147:481\u20137.","journal-title":"Gynecol Oncol"},{"key":"1434_CR11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.4569","volume":"237","author":"J Chen","year":"2015","unstructured":"Chen J, Wang Y, McMonechy MK, Anglesio MS, Yang W, Senz J, et al. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis. J Pathol. 2015;237:215\u201325.","journal-title":"J Pathol"},{"key":"1434_CR12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.neo.2015.08.003","volume":"17","author":"Y Wang","year":"2015","unstructured":"Wang Y, Chen J, Yang W, Mo F, Senz J, Yap D, et al. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors. Neoplasia. 2015;17:650\u201360.","journal-title":"Neoplasia"},{"key":"1434_CR13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1102903","volume":"366","author":"A Heravi-Moussavi","year":"2012","unstructured":"Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med. 2012;366:234\u201342.","journal-title":"N Engl J Med"},{"key":"1434_CR14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/path.4135","volume":"229","author":"MS Anglesio","year":"2013","unstructured":"Anglesio MS, Wang Y, Yang W, Senz J, Wan A, Heravi-Moussavi A, et al. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. J Pathol. 2013;229:400\u20139.","journal-title":"J Pathol"},{"key":"1434_CR15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1261\/rna.032680.112","volume":"18","author":"AM Gurtan","year":"2012","unstructured":"Gurtan AM, Lu V, Bhutkar A, Sharp PA. In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. RNA. 2012;18:1116\u201322.","journal-title":"RNA"},{"key":"1434_CR16","doi-asserted-by":"crossref","first-page":"101042831769596","DOI":"10.1177\/1010428317695967","volume":"39","author":"XJ Wang","year":"2017","unstructured":"Wang XJ, Jiang FZ, Tong H, Ke JQ, Li YR, Zhang HL, et al. Dicer1 dysfunction promotes stemness and aggression in endometrial carcinoma. Tumour Biol. 2017;39:1010428317695967.","journal-title":"Tumour Biol"},{"key":"1434_CR17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s13277-011-0179-0","volume":"32","author":"A Torres","year":"2011","unstructured":"Torres A, Torres K, Paszkowski T, Jodlowska-Jedrych B, Radomanski T, Ksiazek A, et al. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol. 2011;32:769\u201376.","journal-title":"Tumour Biol"},{"key":"1434_CR18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/cncr.25665","volume":"117","author":"I Zighelboim","year":"2011","unstructured":"Zighelboim I, Reinhart AJ, Gao F, Schmidt AP, Mutch DG, Thaker PH, et al. DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma. Cancer. 2011;117:1446\u201353.","journal-title":"Cancer"},{"key":"1434_CR19","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/me.2012-1042","volume":"26","author":"SM Hawkins","year":"2012","unstructured":"Hawkins SM, Andreu-Vieyra CV, Kim TH, Jeong JW, Hodgson MC, Chen R, et al. Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer. Mol Endocrinol. 2012;26:1552\u201366.","journal-title":"Mol Endocrinol"},{"key":"1434_CR20","first-page":"3935","volume":"57","author":"H Tashiro","year":"1997","unstructured":"Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 1997;57:3935\u201340.","journal-title":"Cancer Res"},{"key":"1434_CR21","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","volume":"68","author":"T Daikoku","year":"2008","unstructured":"Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, et al. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008;68:5619\u201327.","journal-title":"Cancer Res"},{"key":"1434_CR22","doi-asserted-by":"crossref","unstructured":"Pandita P, Wang X, Jones DE, Collins K, Hawkins SM. Unique molecular features in high-risk histology endometrial cancers. Cancers. 2019;11:1665.","DOI":"10.3390\/cancers11111665"},{"key":"1434_CR23","first-page":"319","volume":"49","author":"MH Ullman-Cullere","year":"1999","unstructured":"Ullman-Cullere MH, Foltz CJ. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci. 1999;49:319\u201323.","journal-title":"Lab Anim Sci"},{"key":"1434_CR24","first-page":"93","volume":"94","author":"X Wang","year":"2016","unstructured":"Wang X, Khatri S, Broaddus R, Wang Z, Hawkins SM. Deletion of Arid1a in reproductive tract mesenchymal cells reduces fertility in female mice. Biol Reprod. 2016;94:93.","journal-title":"Biol Reprod"},{"issue":"Suppl 1","key":"1434_CR25","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/PGP.0000000000000518","volume":"38","author":"RA Soslow","year":"2019","unstructured":"Soslow RA, Tornos C, Park KJ, Malpica A, Matias-Guiu X, Oliva E, et al. Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019;38 Suppl 1:S64\u2013S74.","journal-title":"Int J Gynecol Pathol"},{"key":"1434_CR26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"1434_CR27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"1434_CR28","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1434_CR29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1210\/me.2010-0371","volume":"25","author":"SM Hawkins","year":"2011","unstructured":"Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, et al. Functional microRNA involved in endometriosis. Mol Endocrinol. 2011;25:821\u201332.","journal-title":"Mol Endocrinol"},{"key":"1434_CR30","doi-asserted-by":"crossref","first-page":"W130","DOI":"10.1093\/nar\/gkx356","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang J, Vasaikar S, Shi Z, Greer M, Zhang B. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 2017;45:W130\u2013W137.","journal-title":"Nucleic Acids Res"},{"key":"1434_CR31","doi-asserted-by":"crossref","first-page":"D163","DOI":"10.1093\/nar\/gkq1107","volume":"39","author":"SD Hsu","year":"2011","unstructured":"Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 2011;39:D163\u2013169.","journal-title":"Nucleic Acids Res"},{"key":"1434_CR32","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/1097-0142(19820615)49:12<2547::AID-CNCR2820491224>3.0.CO;2-0","volume":"49","author":"RJ Kurman","year":"1982","unstructured":"Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer. 1982;49:2547\u201359.","journal-title":"Cancer"},{"key":"1434_CR33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gene.20098","volume":"41","author":"SM Soyal","year":"2005","unstructured":"Soyal SM, Mukherjee A, Lee KY, Li J, Li H, DeMayo FJ, et al. Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis. 2005;41:58\u201366.","journal-title":"Genesis"},{"key":"1434_CR34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000000436","volume":"39","author":"D Lim","year":"2015","unstructured":"Lim D, Ip PP, Cheung AN, Kiyokawa T, Oliva E. Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma. Am J Surg Pathol. 2015;39:1061\u20139.","journal-title":"Am J Surg Pathol"},{"key":"1434_CR35","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","volume":"38","author":"R Murali","year":"2019","unstructured":"Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, et al. High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol. 2019;38:S40\u2013S63.","journal-title":"Int J Gynecol Pathol"},{"key":"1434_CR36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/153303461000900207","volume":"9","author":"Y Wang","year":"2010","unstructured":"Wang Y, Yang D, Cogdell D, Hu L, Xue F, Broaddus R, et al. Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma. Technol Cancer Res Treat. 2010;9:179\u201389.","journal-title":"Technol Cancer Res Treat"},{"key":"1434_CR37","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2006-7-4-r28","volume":"7","author":"CJ Creighton","year":"2006","unstructured":"Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, Chinnaiyan AM, et al. Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol. 2006;7:R28.","journal-title":"Genome Biol"},{"key":"1434_CR38","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/en.2005-0016","volume":"146","author":"JW Jeong","year":"2005","unstructured":"Jeong JW, Lee KY, Kwak I, White LD, Hilsenbeck SG, Lydon JP, et al. Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. Endocrinology. 2005;146:3490\u2013505.","journal-title":"Endocrinology"},{"key":"1434_CR39","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/cncr.24335","volume":"115","author":"AA Kamat","year":"2009","unstructured":"Kamat AA, Coffey D, Merritt WM, Nugent E, Urbauer D, Lin YG, et al. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer. 2009;115:2684\u201392.","journal-title":"Cancer"},{"key":"1434_CR40","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/cbt.10.12.13582","volume":"10","author":"WM Merritt","year":"2010","unstructured":"Merritt WM, Kamat AA, Hwang JY, Bottsford-Miller J, Lu C, Lin YG, et al. Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. Cancer Biol Ther. 2010;10:1306\u201314.","journal-title":"Cancer Biol Ther"},{"key":"1434_CR41","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1002\/pmic.201100102","volume":"11","author":"H Ji","year":"2011","unstructured":"Ji H, Goode RJ, Vaillant F, Mathivanan S, Kapp EA, Mathias RA, et al. Proteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations. Proteomics. 2011;11:4029\u201339.","journal-title":"Proteomics"},{"key":"1434_CR42","doi-asserted-by":"crossref","first-page":"E5883","DOI":"10.1073\/pnas.1518382112","volume":"112","author":"NK Hussain","year":"2015","unstructured":"Hussain NK, Thomas GM, Luo J, Huganir RL. Regulation of AMPA receptor subunit GluA1 surface expression by PAK3 phosphorylation. Proc Natl Acad Sci USA. 2015;112:E5883\u20135890.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1434_CR43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2019.01.035","volume":"448","author":"K Nikhil","year":"2019","unstructured":"Nikhil K, Chang L, Viccaro K, Jacobsen M, McGuire C, Satapathy SR, et al. Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer. Cancer Lett. 2019;448:182\u201396.","journal-title":"Cancer Lett"},{"key":"1434_CR44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.18632\/oncotarget.525","volume":"3","author":"E Mashiach-Farkash","year":"2012","unstructured":"Mashiach-Farkash E, Rak R, Elad-Sfadia G, Haklai R, Carmeli S, Kloog Y, et al. Computer-based identification of a novel LIMK1\/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton. Oncotarget. 2012;3:629\u201339.","journal-title":"Oncotarget"},{"key":"1434_CR45","doi-asserted-by":"crossref","unstructured":"Bian Y, Guo J, Qiao L, Sun X. miR-3189-3p Mimics enhance the effects of S100A4 siRNA on the inhibition of proliferation and migration of gastric cancer cells by targeting CFL2. Int J Mol Sci. 2018;19:236.","DOI":"10.3390\/ijms19010236"},{"key":"1434_CR46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92\u2013105.","journal-title":"Genome Res"},{"key":"1434_CR47","doi-asserted-by":"crossref","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46:D296\u2013D302.","journal-title":"Nucleic Acids Res"},{"key":"1434_CR48","first-page":"D148","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48:D148\u2013D154.","journal-title":"Nucleic Acids Res"},{"key":"1434_CR49","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1073\/pnas.1806862116","volume":"116","author":"M Kriseman","year":"2019","unstructured":"Kriseman M, Monsivais D, Agno J, Masand RP, Creighton CJ, Matzuk MM. Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer. Proc Natl Acad Sci USA. 2019;116:3873\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1434_CR50","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.1806838116","volume":"116","author":"D Monsivais","year":"2019","unstructured":"Monsivais D, Peng J, Kang Y, Matzuk MM. Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma. Proc Natl Acad Sci USA. 2019;116:3883\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1434_CR51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1101\/gr.084129.108","volume":"19","author":"VA Gennarino","year":"2009","unstructured":"Gennarino VA, Sardiello M, Avellino R, Meola N, Maselli V, Anand S, et al. MicroRNA target prediction by expression analysis of host genes. Genome Res. 2009;19:481\u201390.","journal-title":"Genome Res"},{"key":"1434_CR52","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/en.2009-0008","volume":"150","author":"L Aghajanova","year":"2009","unstructured":"Aghajanova L, Velarde MC, Giudice LC. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis. Endocrinology. 2009;150:3863\u201370.","journal-title":"Endocrinology"},{"key":"1434_CR53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173:291\u2013304. e296.","journal-title":"Cell"},{"key":"1434_CR54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23:703\u201313.","journal-title":"Nat Med"},{"key":"1434_CR55","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.6273er1","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"1434_CR56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"1434_CR57","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/cncr.30745","volume":"123","author":"M Le Gallo","year":"2017","unstructured":"Le Gallo M, Rudd ML, Urick ME, Hansen NF, Zhang S, Program NCS, et al. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing. Cancer. 2017;123:3261\u20138.","journal-title":"Cancer"},{"key":"1434_CR58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","volume":"243","author":"DF DeLair","year":"2017","unstructured":"DeLair DF, Burke KA, Selenica P, Lim RS, Scott SN, Middha S, et al. The genetic landscape of endometrial clear cell carcinomas. J Pathol. 2017;243:230\u201341.","journal-title":"J Pathol"},{"key":"1434_CR59","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","volume":"37","author":"MA Clarke","year":"2019","unstructured":"Clarke MA, Devesa SS, Harvey SV, Wentzensen N. Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers. J Clin Oncol. 2019;37:1895\u2013908.","journal-title":"J Clin Oncol"},{"key":"1434_CR60","unstructured":"Schultz KAP, Stewart DR, Kamihara J, Bauer AJ, Merideth MA, Stratton P, et al. DICER1 tumor predisposition. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. Seattle (WA): GeneReviews((R)); 1993."},{"key":"1434_CR61","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41379-018-0132-5","volume":"32","author":"GR Bean","year":"2019","unstructured":"Bean GR, Anderson J, Sangoi AR, Krings G, Garg K. DICER1 mutations are frequent in mullerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation. Mod Pathol. 2019;32:280\u20139.","journal-title":"Mod Pathol"},{"key":"1434_CR62","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41379-019-0436-0","volume":"33","author":"L de Kock","year":"2020","unstructured":"de Kock L, Yoon JY, Apellaniz-Ruiz M, Pelletier D, McCluggage WG, Stewart CJR, et al. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma. Mod Pathol. 2020;33:1207\u201319.","journal-title":"Mod Pathol"},{"key":"1434_CR63","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1158\/1078-0432.CCR-17-0629","volume":"23","author":"KAP Schultz","year":"2017","unstructured":"Schultz KAP, Rednam SP, Kamihara J, Doros L, Achatz MI, Wasserman JD, et al. PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res. 2017;23:e76\u2013e82.","journal-title":"Clin Cancer Res"},{"key":"1434_CR64","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1038\/onc.2013.281","volume":"33","author":"B Zhang","year":"2014","unstructured":"Zhang B, Chen H, Zhang L, Dakhova O, Zhang Y, Lewis MT, et al. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene. 2014;33:3099\u2013108.","journal-title":"Oncogene"},{"key":"1434_CR65","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1101\/gad.1848209","volume":"23","author":"MS Kumar","year":"2009","unstructured":"Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 2009;23:2700\u20134.","journal-title":"Genes Dev"},{"key":"1434_CR66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48133-0","volume":"9","author":"PB Munson","year":"2019","unstructured":"Munson PB, Hall EM, Farina NH, Pass HI, Shukla A. Exosomal miR-16-5p as a target for malignant mesothelioma. Sci Rep. 2019;9:11688.","journal-title":"Sci Rep"},{"key":"1434_CR67","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.2217\/fon.15.101","volume":"11","author":"E Huang","year":"2015","unstructured":"Huang E, Liu R, Chu Y. miRNA-15a\/16: as tumor suppressors and more. Future Oncol. 2015;11:2351\u201363.","journal-title":"Future Oncol"},{"key":"1434_CR68","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.18632\/oncotarget.14586","volume":"8","author":"K Ihira","year":"2017","unstructured":"Ihira K, Dong P, Xiong Y, Watari H, Konno Y, Hanley SJ, et al. EZH2 inhibition suppresses endometrial cancer progression via miR-361\/Twist axis. Oncotarget. 2017;8:13509\u201320.","journal-title":"Oncotarget"},{"key":"1434_CR69","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/bjc.2015.369","volume":"113","author":"Y Ikeda","year":"2015","unstructured":"Ikeda Y, Oda K, Ishihara H, Wada-Hiraike O, Miyasaka A, Kashiyama T, et al. Prognostic importance of CDK4\/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy. Br J Cancer. 2015;113:1477\u201383.","journal-title":"Br J Cancer"},{"key":"1434_CR70","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.4896","volume":"242","author":"MA Dosil","year":"2017","unstructured":"Dosil MA, Mirantes C, Eritja N, Felip I, Navaridas R, Gatius S, et al. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias. J Pathol. 2017;242:152\u201364.","journal-title":"J Pathol"},{"key":"1434_CR71","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","volume":"109","author":"J Kim","year":"2012","unstructured":"Kim J, Coffey DM, Creighton CJ, Yu Z, Hawkins SM, Matzuk MM. High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci USA. 2012;109:3921\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1434_CR72","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ijc.28746","volume":"135","author":"PH van der Horst","year":"2014","unstructured":"van der Horst PH, van der Zee M, Heijmans-Antonissen C, Jia Y, DeMayo FJ, Lydon JP, et al. A mouse model for endometrioid ovarian cancer arising from the distal oviduct. Int J Cancer. 2014;135:1028\u201337.","journal-title":"Int J Cancer"},{"key":"1434_CR73","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/PAI.0000000000000350","volume":"25","author":"JA Al-Maghrabi","year":"2017","unstructured":"Al-Maghrabi JA, Butt NS, Anfinan N, Sait K, Sait H, Marzouki A, et al. Infrequent immunohistochemical expression of Napsin A in endometrial carcinomas. Appl Immunohistochem Mol Morphol. 2017;25:632\u20138.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1434_CR74","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","volume":"26","author":"G Han","year":"2013","unstructured":"Han G, Sidhu D, Duggan MA, Arseneau J, Cesari M, Clement PB, et al. Reproducibility of histological cell type in high-grade endometrial carcinoma. Mod Pathol. 2013;26:1594\u2013604.","journal-title":"Mod Pathol"},{"key":"1434_CR75","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","volume":"11","author":"KK Zorn","year":"2005","unstructured":"Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res. 2005;11:6422\u201330.","journal-title":"Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01434-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01434-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T19:19:59Z","timestamp":1629832799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01434-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":75,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2020,10,1]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-01434-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}